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Abstract
Background: Extracellular ATP is an important signaling molecule for vascular adaptation to limited oxygen availability
(hypoxia). Here, we pursued the contribution of vascular endothelia to extracellular ATP release under hypoxic conditions.
Methodology, Principal Findings: We gained first insight from studying ATP release from endothelia (HMEC-1) pre-exposed
to hypoxia. Surprisingly, we found that ATP release was significantly attenuated following hypoxia exposure (2% oxygen,
2263% after 48 h). In contrast, intracellular ATP was unchanged. Similarly, lactate-dehydrogenase release into the
supernatants was similar between normoxic or hypoxic endothelia, suggesting that differences in lytic ATP release between
normoxia or hypoxia are minimal. Next, we used pharmacological strategies to study potential mechanisms for endothelial-
dependent ATP release (eg, verapamil, dipyridamole, 18-alpha-glycyrrhetinic acid, anandamide, connexin-mimetic
peptides). These studies revealed that endothelial ATP release occurs – at least in part - through connexin 43 (Cx43)
hemichannels. A real-time RT-PCR screen of endothelial connexin expression showed selective repression of Cx43 transcript
and additional studies confirmed time-dependent Cx43 mRNA, total and surface protein repression during hypoxia. In
addition, hypoxia resulted in Cx43-serine368 phosphorylation, which is known to switch Cx43 hemi-channels from an open
to a closed state.
Conclusions/Significance: Taken together, these studies implicate endothelial Cx43 in hypoxia-associated repression of
endothelial ATP release.
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Introduction
Extracellular nucleotide and nucleoside levels are increased
during conditions of limited oxygen availability (hypoxia) [1–17]
and have been suggested in various aspects of physiological
adaptation to hypoxia [1–3,5–9,16–19]. Particularly extracellular
elevations of ATP are critical in vascular adaptation to hypoxia, as
extracellular ATP can either signal directly to ATP receptors [20,21]
or is rapidly converted to adenosine leading to increased vascular
nucleoside signaling [22–27]. While previous studies have shown
that during hypoxic conditions, adenosine stems mainly from ATP-
phosphohydrolysis [7,8,26,28] cellular sources and mechanisms for
extracellular ATP release during hypoxia are not well defined. As
such, differentcelltypes can contribute to elevations ofvascular ATP
during hypoxia, including circulating blood cells such as platelets,
erythrocytes or inflammatory cells (e.g. PMN).[29] In addition,
vascular endothelia may represent an important cellular source for
extracellular ATP release during hypoxia [28] as they extend over a
large surface area and are anatomically positioned at the interface
between a hypoxic stimulus and the surrounding tissues [26].
At present, several studies have detailed different molecular
mechanisms involved in cellular release of ATP into the
extracellular milieu. Such mechanisms differ between multiple
cell types (e.g. platelets, astrocytes, umbrella cells of the bladder)
[30]. For example, ATP release from umbrella cells of the bladder
is dependent on mechanical pressure stimulation. This ATP
release can be blocked by inhibitors of connexin hemichannels,
ABC-protein family members, or nucleoside transporters [31].
Other studies on cellular mechanisms of ATP release found that
ATP release from neuronal astrocytes involves the gap-junction
molecule connexin 43 (Cx43) [32]. As such, Cx43 molecules can
assemble to hexadimers (so called ‘‘connexons’’) that form
junctional connections between different cell types. In addition
to their role as gap-junctional proteins, recent studies indicate that
Cx43 connexons are also active in single plasma membranes and
can function in intercellular signaling as ATP release channels
[33]. As such, genetic and pharmacological studies of neutrophil-
dependent ATP release suggest a critical role of Cx43-hemi-
channels in extracellular ATP release following inflammatory
stimulation [29], which may play an important role in purinergic
chemotaxis [34,35]. Similarly, a very recent study studied the
contribution of Cx43 to ovarian follicle development in the mouse.
The authors found that Cx43 is strongly expressed in granulosa
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couple the cells metabolically. However, recent evidence indicates
that undocked gap junction hemichannels can also have
physiological roles such as mediating the release of small
messenger molecules, including ATP. In this study, the presence
of undocked Cx43 hemichannels in granulosa cells was revealed
by dye uptake induced either by mechanical stimulation or by the
reduction of extracellular divalent cations, both of which are
known triggers for hemichannel opening. ATP release was also
detected, and could be abolished by connexin-channel blockers
[36].
In the present study, we tested the hypothesis that vascular
endothelia represent an important source for extracellular ATP
elevation during hypoxic conditions. To our surprise, we found
that extracellular ATP release from vascular endothelia is
attenuated following hypoxia exposure. Additional studies to
address molecular mechanisms of endothelial-dependent ATP
release suggested a functional contribution of Cx43 in endothe-
lial ATP release. Moreover, hypoxia exposure of endothelia
revealed that Cx43 expression is attenuated by hypoxia, while
Cx43-Serine368 phosphorylation status is increased, which has
previously been shown to change the Cx43 channels from an
open to a closed status [37]. These findings suggest that
extracellular elevations of vascular ATP levels during hypoxia
predominantly stem from other cell types than vascular
endothelia (e.g. inflammatory cells, or red blood cells)
[29,35,38,39].
Materials and Methods
Endothelial Cell Culture
Human microvascular endothelial cells (HMEC-1) were a kind
gift of Francisco Candal, Centers for Disease Control, Atlanta, GA
[40,41]. These cells are derived from dermal tissues and were
harvested and cultured by a modification of methods described
previously [9,23–25,29,42]. In brief, HMEC-1 were harvested
with 0.1% trypsin and incubated at 37uC in 95% air/5% CO2.
Culture medium was supplemented with heat-inactivated fetal
bovine serum, penicillin, streptomycin, L-glutamine, epidermal
growth factor, and hydrocortisone. In other studies, human
umbilical vein endothelial cells (HUVECs) were cultured as
described previously [26,43]. All experiments were carried out
when cultured endothelial cells were fully confluent.
Measurement of extracellular ATP release into the
supernatant from HMEC-1
Confluent HMEC-1 monolayers were exposed to normoxia or
indicated time periods of hypoxia (2% oxygen). These studies were
carried out in the presence of the polyoxotungstate
Na6[H2W12O40] (POM-1, 100 mM), a highly potent non-specific
inhibitor of ecto-nucleoside triphosphate diphosphohydrolases [7].
The culture medium was removed, cells were washed twice and
incubated as indicated in calcium containing HBSS, and samples
from the supernatant were collected, shock frozen and stored at
280uC for further analysis. In subsets of experiments, intracellular
ATP levels were measured. Here, confluent HMEC-1 monolayers
were exposed to hypotonic lysis by addition of ice-cold water.
Following centrifugation over for 5 min at 13,000 rpm, the ATP
content in the supernatants was quantified using a highly sensitive
luciferase based technique (CHRONO-LUME, Chrono-Log
Corp., USA, Haverton). Luciferase activity was measured on a
luminometer (Turner Designs Inc., Sunnyvale, California, USA)
and compared with ATP standards [26,29].
Measurment of lactate dehydrogenase (LDH) in
supernatants from HMEC-1
To assess lytic ATP release, the cytotoxicity detection kit (Roche
Diagnostics, Germany, Mannheim) was used according to the
manufacture’s instructions.[29] In short, confluent HMEC-1 mono-
layers were exposed to normoxic or hypoxic (2% oxygen) conditions
over indicated time periods, then 100 ml of the substrate mixturefrom
the kit were added to 100 ml of the collected protein-free supernatant.
After an incubation period of 30 min the absorbance was measured
at 490 nm. In control studies, normoxic HMEC-1 were treated with
2% Triton X-100 to assess maximal LDH release.
Pharmacological studies on mechanisms of endothelial-
dependent ATP release
Confluent HMEC-1 were seeded on 6-well plates, culture
medium was removed and cells were washed with calcium free
5 M HEPES HBSS. In subsets of experiments, HMEC-1 monolay-
ers were pretreated over 10 min with 18-alpha-glycyrrhetinic acid
(18aGA; Sigma Aldrich, 20 mmol), Anandamide (Sigma Aldrich,
40 mmol) or the phosphokinase C inhibitor bisindolylmaleimide
(BIM, Sigma Aldrich, 10 mM). Furthermore, the non specific ABC
receptor antagonist Verapamil (Tocris Cookson, 10 mmol) and the
inhibitor of equilibrative nucleoside transporters dipyridamole
(Sigma Aldrich, 10 mmol) were used. In other studies, the effects of
connexin mimetic peptides for connexin 43 (SRPTEKTIFII,
Biosource, Germany, Solingen, 50 mmol) and connexin 40
(SRPTEKNVFIV, Biosource, Germany, Solingen, 50 mmol) were
used (100 mM). After 30 min of incubation time at room
temperature, ATP content within the supernatants was measured
as described above. Connexin mimetic peptides that correspond to
short specific sequences in the two extracellular loops of connexins
are a class of benign, specific and reversible inhibitors of gap-
junctionalcommunicationthathavebeenstudiedrecentlyinabroad
range of cells, tissues and organs. The properties and uses of these
short synthetic peptides, and their probable mechanism of action
with those of a wide range of other less specific traditional gap-
junction inhibitors have been recently reviewed [44].
Transcriptional analysis
To assess the influence of hypoxia on enthothelial connexin
transcript levels, HMEC-1 monolayers were exposed to hypoxia
(2% oxygen) over indicated time periods, followed by isolation of
RNA and quantification of transcript levels by real-time RT-PCR
(iCycler; Bio-Rad Laboratories Inc.). RNA was isolated by using
Total RNA purification NucleoSpin RNA II according to the
manufacturer’s instructions (Marcherey-Nagel, Germany, Du ¨ren).
RNA concentration was measured followed by cDNA synthesis
using the iScript cDNA Synthesis Kit (Bio-Rad Laboratories). The
PCR reactions contained 10 pM sense and 10 pM antisense
oligonucleotides with iQ SYBR Green Supermix (Bio-Rad
Laboratories). The target sequence was amplified using increasing
numbers of cycles of 95uC for 15 s, 56uC for 30 s, 72uC for 15 s as
described previously [26,42]. Realtime RT-PCR conditions and
primer sequences are summarized in Table 1.
Western blot analysis
Cx43 expression and phosphorylation status were assessed by
Western blot analysis using connexin 43 rabbit polyclonal antibody
(Cell Signaling) or phospho-connexin 43 rabbit polyclonal antibody
detecting serine 368 phosphorylated Cx43 (Cell Signaling) as
described previously.[29] In subsets of experiments, HMEC-1 were
pre-treated with the phosphokinase C (PKC) inhibitor bisindolyma-
leimid during hypoxia or normoxia exposure (10 mM) [45].
Endothelial ATP Release
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SurfaceCx43expression wasassessed asdescribed previously.[29]
In short, confluent HMEC-1 were exposed to normoxia or indicated
time periods of hypoxia (2% oxygen). Monolayers were washed,
surface proteins labeled with biotin, lysed and centrifugated to
remove cell debris. Protein concentration was measured and
immunoprecipitation was performed with 2 mgm o n o c l o n a lr a b b i t
anti-mouse connexin 43 antibody (Acris) and incubated overnight.
Subsequently, 50 ml Protein G Microbeads (Miltenyi Biotec) were
added and incubated for 30 minutes on ice. Magnetically separated
immune complexes were eluated with 16SDS gel loading buffer,
transferredtonitrocellulose,and blockedovernightinwashing buffer
with 3% BSA and 2 mg/ml streptavidine. Membranes were
enhanced by alkaline phosphatase.
Data analysis
Data were compared by two-factor ANOVA, or by Student’s t
test where appropriate. Values are expressed as the mean6SD
from at least three separate experiments. Standard deviation error
bars at baseline (time point 0) reflect differences between different
experiments.
Results
Extracellular ATP release from vascular endothelia is
attenuated by hypoxia
To study the role of vascular endothelia in extracellular ATP
release, we first measured the extracellular ATP content within the
supernatant of vascular endothelia. For this purpose, the culture
media from confluent HMEC-1 monolayers was replaced with
calcium containing HBSS, and samples from the supernatant were
collected at indicated time points, in the presence of POM-1, a
highly potent ENTPDase inhibitor [6,7]. As shown in Figure 1A,
ATP levels within the supernatant immediately rise to approxi-
mately 90 nM and remained stable over the examined time period
of 180 min. The present results are consistent with other studies
that have measured ATP release from endothelial cells or
fibroblasts. In these studies, the authors found maximal ATP
levels at 10 min (their earliest measurement point, fibroblasts) or
30 min (endothelia) and no additional elevation at later points (e.g.
at 60 min or 24 h). In fact, ATP levels were attenuated at these
later measurement points. To rule out acute effects of changing the
media (e.g. cell lysis initiated by media change), all further
measurements were carried out 30 min after changing the media.
To study the influence of hypoxia on vascular ATP release, we
pre-exposed over vascular endothelia (HMEC-1) over indicated
periods to normoxia (21% oxygen) or ambient hypoxia (2%
oxygen), the media was replaced and ATP content was measured
within the supernatants after 30 min of incubation time.
Surprisingly, we found that extracellular ATP levels were lower
in supernatants derived from post-hypoxic endothelia in a time-
dose dependent fashion, suggesting that endothelial ATP release is
attenuated by hypoxia (Figure 1B). As next step, we lysed cells
following different time-periods of hypoxia exposure and mea-
sured intracellular ATP levels. As shown in Figure 1C, intracel-
lular ATP levels were unchanged in post-hypoxic endothelia. This
is important, as changes in extracellular ATP release with hypoxia
as shown in Figure 1B could be caused by attenuated intracellular
ATP content, thereby resulting in an overall decrease in the
transcellular ATP gradient during hypoxia. To study the degree of
hypoxia that is necessary for attenuating endothelial ATP release,
we next performed an oxygen-concentration dose-response curve
with oxygen concentrations spanning the physiological range from
Table 1. Human primer pairs used for real-time RT-PCR.
Human Forward (59–39) Reverse (59–39) Product [bp] Temp [Cu]
ß-actin GGTGGCTTTTAGGATGGCAAG ACTGGAACGGTGAAGGTGACAG 162 56
Cx 25 CAGGCCTCTTGCCGATTCAG GTGGCCTCCACTTCCTATCA 215 56
Cx 26 AAGAAGTCGCTTGGGAATTT GCTGAAGGGGTAAGCAAACA 177 56
Cx 30 TCCAGAAGGCAATACCAACC CAATGCTCC TTTGTCAAGCA 180 56
Cx 30.3 AGAGGTGCATGGAGATCTTC CAGCCTTCATTAGGACAGAG 135 56
Cx 31 CTTCCAGCAGCAGCAGGTCT CACCAGCCTGAGCACAGTTG 181 56
Cx 31.1 ATCTACCTGGTGAGCAAGAG GAGAGGAGGATGACTGTCTG 162 56
Cx 31.3 GAGAACCTTGCCTTGGTAGT TTGTGTCTTCTGGTGCTCTC 214 56
Cx 31.9 GACCGTCTTCGTGCTCTTCT AGCAGCTTCTGCGCCTCTTC 153 56
Cx 32 TCCGACAGCGTCTCCAATTA TTGTGGCCAGCAAGCACTAT 187 56
Cx 36 GCATCAAGGAGGTGGAATGT TTGAGTTCAGCCAGGTTGAG 112 56
Cx 37 CAACAGAGGGGTCCTGAGAA CTGGAGAGGAAGCCGTAGTG 182 56
Cx 40 AGCAGGGGCAAGGAAATAGT TACAGAGACCAGGCCAATCC 162 56
Cx 40.1 GCCGTCTTCAGCGTCTATGT GAGGAGGAGGTGGATGATGT 180 56
Cx 43 AATTCAGACAAGGCCCACAG CATGGCTTGATTCCCTGACT 216 56
Cx 45 ACGCTTGGATCTGGCAGTTC TCAGTGAGCTGCTGCTTACC 209 56
Cx 46 TTCGAGCTGAAGCCGCTCTA CGCCAGCATGAAGATGATGA 111 56
Cx 47 GACCACCGTGTGGATCTGAG CGGCTAAGGAGAAGGCTGAG 113 56
Cx 50 CTCCACTCCATTGCTGTCTC CGTAGGAAGGCAGTGTCTCT 217 56
Cx 59 AAGAGACCACAGCCTTAGGA AGGAGTCCAGTCTAGAAGGA 118 56
Cx 60 CAGTGAAGGCAGCATGAGAG TGACTGAAGGCAGAGGTGAG 197 56
doi:10.1371/journal.pone.0002801.t001
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cells (HMEC-1) over 24 h to indicated concentrations of oxygen,
ranging from normoxia (21% oxygen) to severe hypoxia (2%
oxygen). As shown in Figure 1D, attenuated ATP release occurred
only with more severe hypoxia (4% or 2% oxygen over 24 h). To
study the contribution of lytic ATP release, we measured LDH
content in the supernatants of post-hypoxic endothelia. As shown
in Figure 1F, LDH content in the supernatant (obtained 30 min
after changing the media) did not change significantly with
hypoxia exposure, suggesting that lytic ATP release did not
account for differences between normoxic or post-hypoxic
endothelial ATP release. Taken together, these studies demon-
strate that ambient hypoxia of vascular endothelia results in
decreased extracellular ATP release.
Figure 1. Endothelial ATP release during hypoxia. A, To study extracellular ATP releasefromnormoxic endothelia, monolayers of confluentHMEC-
1 were washedandtheculture media was replacewithcalciumcontainingHBSS. ATP content from their supernatantwas sampledat indicatedtime points
and quantified using a luminometric ATP detection assay. B, To measure extracellular ATP release under hypoxic conditions, confluent HMEC-1 monolayers
were exposed to hypoxia (2% oxygen) over indicated time periods. Culture media was replaced with calcium containing HBSS and the ATP content within
thesupernatantwasmeasuredafter30 minincubationtime.C,ForintracellularATPmeasurement,confluentHMEC-1monolayerswereexposedtohypoxia
over indicated time periods, culture medium was discarded and cells were lysed by adding ice-cold water. ATP concentrations were measured as above. D,
To measure theinfluenceof different oxygen concentrations on endothelial ATP release, HMEC-1 were exposed to indicated degrees of hypoxia (21–2% of
oxygen) over 24 h. Culture media was replaced with calcium containing HBSS and the ATP content within the supernatant was measured after 30 min
incubation time. E, Confluent HMEC-1 monolayers were exposed to hypoxia as indicated. To assess lytic ATP release, LDH concentrations within the
supernatant were measured by an LDH detection kit. In control experiments, cells were lysed with Triton X-100 (*p,0.01, n=6 for all experiments).
doi:10.1371/journal.pone.0002801.g001
Endothelial ATP Release
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ATP exists in the cytoplasm at millimolar concentrations[46]
and can be released extracellularly by several mechanisms,
including transport via connexin hemichannels, through nucleo-
side transporters, or direct transport through ATP-binding cassette
(ABC) proteins.[29] As first step, we tested the effect of verapamil,
an inhibitor of several ABC proteins and the multi drug resistance
gene product.[29] As shown in Figure 2A, we found no alteration
in endothelial ATP release with verapamil treatment. Similarly,
the nucleoside transport inhibitor dipyridamole had no effect on
endotheilal ATP release (Figure 2B). Next, we measured ATP
release of endothelia in the presence or absence of the non-specific
gap junction inhibitor 18aGA.[29] As shown in Figure 2C,
addition of 18aGA resulted in a dramatic reduction of ATP
Figure 2. Molecular mechanisms of endothelial-dependent ATP release. A–D, Confluent HMEC-1 monolayers were washed and exposed to
Verapamil (10 mmol) or Dipyridamole (1 mmol) over 20 min, 18-alpha-glycyrrhetinic acid (18aGA, 20 mmol) or Anandamide (40 mmol) over 10 min.
ATP content within the supernatant was measured by a luminometric ATP detection assay and compared with untreated control cells (n=6).
doi:10.1371/journal.pone.0002801.g002
Endothelial ATP Release
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non-specific gap junction inhibitor anandamide [29] resulted in
attenuated ATP release (Figure 2D). We extended these findings to
define specific connexin contributions to endothelial ATP release.
For these purposes, we used previously described connexin
mimetic peptides specifically directed against Cx40 or Cx43
[29,47]. As shown in Figure 3A, the Cx40-specific connexin
mimetic peptide did not alter ATP liberation from endothelia. By
contrast, the peptides which block Cx43 showed a significant
inhibition of ATP liberation (50.067% reduction, p,0.01 by
ANOVA, Figure 3B). These results implicate Cx43 in ATP release
from human endothelia.
Modulation of endothelial connexin expression by
hypoxia
Based on our observations of attenuated ATP release by
endothelia following hypoxia exposure and our data showing that
gap-junctional inhibition is associated with attenuated endothelial
ATP release, we next studied transcriptional consequences of
hypoxia on endothelial connexin expression. Here, we first
performed a transcriptional screen of known connexin mole-
cules[48] using realtime RT-PCR to compare normoxic or
hypoxic connexin expression of HMEC-1 (Table 1). Serendipi-
tously, these studies revealed a selective repression of Cx43
transcript levels with hypoxia exposure (Figure 4, 2% oxygen, 12 h
of hypoxia), while transcript levels of other connexins were not
observed. As shown in Figure 5A, these results could be
confirmed with different time periods of hypoxia exposure
(Figure 5A) and in a different human endothelial cell line
(HMEC-1 and HUVECs, Figure 5A and B). The percentage of
Cx43 repression and kinetics are slightly different between both
cell types. However, the overall observation of significant
repression of Cx43 expression with hypoxia is consistent between
both cell lines. The reasons for these differences between
HUCECs and HMEC-1 remain unclear to the authors. Western
blot analysis showed time-dependent repression of Cx43 protein
(Figure 5C) and immunoprecipitation localized attenuated Cx43
protein levels to the cell surface (Figure 5D). As previous studies
had shown that PKC-dependent phosphoylation of the serin368
residue of Cx43 is associated with a functional change of Cx43
channels from the open to the closed state [37,49], we next
studied Cx43-serine368 phosphorylation status by Western blot
analysis using a serin368 phospho-specific antibody for Cx43. As
shown in Figure 5E, hypoxia was also associated with increased
phosphorylation of Cx43-Serine368. Consistent with previous
reports, this response could be attenuated with the PKC
inhibitor BIM (no changes in beta actin were observed, data
not shown) [37,49]. Taken together these studies reveal hypoxia-
dependent repression of Cx43 transcript in conjunction with
increased phosphorylation of Cx43-Serine368, suggesting that
hypoxia attenuates endothelial ATP release by transcriptional
repression and phosphorylation of Cx43.
Functional consequences of Cx43 phosphorylation on
endothelial ATP release
We next pursued studies to address whether hypoxia-
associated phosphorylation of Cx43 contributes to attenuated
ATP release from vascular endothelia. Here, we measured
e n d o t h e l i a lA T Pr e l e a s ei nf o l l o w i n gP K Ci n h i b i t i o nw i t hB I M
to attenuate Cx43-Serine368 (see above) under normoxic or
Figure 3. Connexin-mimetic peptides in endothelial ATP
release. A, B, Confluent HMEC-1 monolayers were washed and treated
with connexin-mimetic peptides (A: Cx40 peptide, SRPTEKNVFIV,
50 mmol; B: Cx43 peptide, SRPTEKTIFII, 50 mmol). ATP content within
the supernatant was measured by a luminometric ATP detection assay
after an incubation period of 20 min and compared with control HMEC-
1 treated with 50 mM bovine albumin (n=6).
doi:10.1371/journal.pone.0002801.g003
Figure 4. Endothelial connexin expression. Confluent HMEC-1
monolayers were exposed to normoxia or hypoxia (12 h). Total RNA was
isolated and real-time reverse-transcriptase polymerase chain reaction
was employed to screen for transcriptional modulation of connexin
expression. Data were calculated relative to an internal control gene (b-
actin) and are expressed as fold change over normoxia at each time
point. Results are derived from 3 experiments in each condition.
doi:10.1371/journal.pone.0002801.g004
Endothelial ATP Release
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revealed that already under normoxic conditions ATP release
was significantly increased following PKC inhibition (Figure 6A)
as compared to untreated normoxic HMEC-1 (p,0.05). While
hypoxia exposure of untreated HMEC-1 was associated with a
significant attenuation of ATP release (p,0.001), this response
was completed abolished following PKC inhibition with BIM. In
fact, BIM treated HMEC-1 had higher ATP levels within the
supernatant than untreated normoxic HMEC-1 (p,0.05). Taken
together, these data suggest a functional contribution of Cx43
phosphorylation in attenuating endothelial ATP release during
conditions of hypoxia.
Figure 5. Influence of hypoxia on Connexin 43 expression. A, B. Confluent HMEC-1 or HUVEC monolayers were exposed to normoxia or
hypoxia (2% oxygen) over indicated time periods. Total RNA was isolated and transcriptional responses were assessed by real-time reverse-
transcriptase polymerase chain reaction. Data were calculated relative to an internal housekeeping gene (b-actin) and are expressed as fold change
over normoxia at each time point. Results are derived from 3 experiments in each condition. C. Confluent HMEC-1 monolayers were exposed to
hypoxia over indicated time periods. Cells were lysed and proteins were resolved by SDS-PAGE and transferred to PVDF-membrane. Membranes were
probed with a connexin 43 antibody, proteins were detected by chemiluminescene. The same blot was reprobed for b-actin as a control for protein
loading. A representative experiment of 3 is shown. D. Confluent HMEC-1 monolayers were exposed to hypoxia over indicated time periods.
Monolayers were washed, surface proteins were biotinylated, and cells were lysed. Connexin 43 was immunoprecipitated, followed by addition of
Protein G Microbeads. Proteins were resolved by SDS-PAGE and resultant Western blots were probed with Streptavidin. A representative experiment
of 3 is shown. E. Confluent HMEC-1 monolayers were exposed to normoxia or hypoxia over indicated time periods. Cells were lysed and proteins were
resolved by SDS-PAGE and transferred to PVDF-Membrane. Membranes were probed with phospho-connexin 43 antibody specific for
phosphorylated ser368, and proteins were detected by chemiluminescene. The same blot was probed for b-actin as a control for protein loading.
A representative of 3 is shown. In subsets of experiments, cells were pretreated with the protein kinase C inhibitor bisindolylmaleimide (10 mM; +BIM).
doi:10.1371/journal.pone.0002801.g005
Endothelial ATP Release
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The present studies address the contribution of vascular
endothelia to extracellular ATP elevations during conditions of
hypoxia. While extracellular ATP levels are generally elevated
during limited oxygen availability,[28] the results from our studies
point out that endothelial ATP release is actually attenuated by
hypoxia exposure. These findings suggest that other cellular
sources (e.g. platelets, red blood cells or inflammatory cells)
[29,35,38,39] could account for extracellular ATP elevations
during limited oxygen availability or provide a ‘‘trigger’’ for other
cells to release ATP. In addition, the present studies address
molecular mechanisms involved in endothelial ATP release.
Consistent with previous studies suggesting a potential role of
endothelial Cx43 hemichannels in extracellular ATP release [47],
the present studies point towards a critical role of Cx43 in
endothelial-dependent ATP release. Moreover, endothelial hyp-
oxia results in transcriptional repression of Cx43 in conjunction
with increased phosphorylation status of Cx43- ser368, thereby
resulting in hypoxia-associated attenuation of ATP-release.
In contrast to the present studies, a previous study of endothelial
ATP release during hypoxia found increased extracellular ATP
release from pulmonary endothelia following hypoxia exposure
[28]. Why these results are different from the present studies is
currently unclear. A possible explanation may involve the fact, that
pulmonary endothelia that were used in the studies by Gerasi-
movskaya et al. may be different in their responses to hypoxia than
vascular endothelial cells that were used in the present studies (e.g.
HMEC-1). As such, baseline levels of ATP release measured in the
present studies of HMEC-1 were close to 100 nM, whereas
baseline ATP levels measured by Gerasimoskaya et al. in
pulmonary endothelia were approximately 0.2 nM. Moreover,
differences in the dynamics of extracellular ATP metabolism in
different cellular models or hypoxic conditions could also
contribute to the differences between both studies. In addition,
one has tokeep in mind that both studies did not really measure a
release rate but an instantaneous concentration that will be the
result of a omplex mixture of cell volume, media volume, and
degredation rates compared to release rates, thus making it
difficult to compare both experimental settings.
The findings from the present studies highlight the role of
extracellular ATP release as part of a crosstalk pathway between
different cell-types during conditions of hypoxia. The fact that
endothelial ATP release is attenuated following hypoxia exposure
suggests that other cellular components of the vasculature (e.g.
smooth muscle cells, fibroblasts, platelets, red blood cells or
inflammatory cells) [29,35,38,39] have to account for hypoxia-
associated increase in extracellular ATP. For example, non-
resident cells like PMN that participate in an endothelial-
neutrophil dependent crosstalk may therefore represent an
important source of extracelluar ATP [25]. In fact, extracellular
ATP can be rapidly metabolized to adenosine by hypoxia-induced
ectonucleotidases (CD39, ecto-apyrase, conversion of ATP to
AMP and CD73, ecto-59-nucleotidase, AMP to adenosine)
expressed on the endothelial surface, thereby contributing to
endothelial adaptation to hypoxia. In fact, different studies have
shown that during conditions of hypoxia or ischemia, the main
source of extracellular adenosine stems from phosphohydrolysis of
precursor molecules, particularly ATP [5–8,26]. For example
studies in mice deficient in extracellular adenosine generation
(cd73
2/2 or cd39
2/2 mice) [26,50] revealed dramatic increases in
vascular leakage and pulmonary edema when mice were exposed
to ambient hypoxia (8% of oxygen over 4 h) [26,50]. In addition, a
recent study of vascular responses to hypoxia compared gene-
targeted mice for each individual adenosine receptor (AR, A1AR,
A2AAR, A2BAR or A3AR) showing a barrier-protective role of
signaling through the A2BAR in attenuating vascular leakage
during hypoxia [27]. Moreover, these studies found resuscitation
of endothelial barrier defects associated with hypoxia by A2BAR
agonist treatment. While our results suggest that the general
elevation of ATP levels observed in hypoxia may emanate from
other cellular sources, it is important to point out that erythrocytes
and platelets lack connexins [51], and thus Cx hemichannels
detract from the importance of such channels in enucleate cells.
Taken together, other cellular sources than endothelia and other
molecular mechanisms than Cx43-dependent ATP release are
likely to contribute to elevating extracellular ATP levels with
hypoxia.
Some limitations of the present studies need to be pointed out.
The essence of this paper is that reduced release of ATP is
atypical. However, a cultured endothelial cell line is not strictly
‘‘endothelium’’. These cells in a blood vessel interact extensively
and multidimensionally with each other and also with smooth
muscle cells and thus it is, after all, a model. In addition, it is may
be surprising to see on the one hand a very strong effect of PKC
inhibition (Fig 6) and on the other hand a downregulation (Fig. 5)
of Cx43. For example, if Cx43 is downregulated, how can it be
assumed that PKC inhibition prevents the ATP release? However,
similar observations in other models have been made previously.
For example, hypoxia is associated with transcriptional repression
of equilibrative nucleoside transporters, particularly ENT1 thereby
resulting in attenuated adenosine uptake from the extracellular
space and enhanced adenosine signaling effects [22,23]. However,
pharmacological inhibition of nucleoside transporters can be used
therapeutically. In this study, treatment with the nucleoside
transport inhibitor dipyridamole was associated with attenuated
vascular leakage during ambient hypoxia exposure of mice (8%
oxygen, 4 h exposure time) [23].
Taken together, the present studies define an important
contribution of endothelial Cx43 to extracellular ATP release
and reveal transcription and phosphorylation dependent attenu-
Figure 6. ATP release from HMEC treated with the protein
kinase C inhibitor bisindolylmaleimide (BIM). To study the role of
Cx43 ser398 phosphorylation status in ATP release from endothelia,
monolayers of confluent HMEC-1 were treated with BIM (+BIM, 10 mM)
or vehicle control (-BIM), exposed to normoxia or hypoxia (24 h, 2%
oxygen), washed and the culture media was replace with calcium
containing HBSS. ATP content from the supernatant was sampled at
indicated time points and quantified using a luminometric ATP
detection assay (*p,0.05 compared to Normoxia – BIM; n=6).
doi:10.1371/journal.pone.0002801.g006
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